Find
21 Jun 2022

Eurex Clearing

EurexOTC Clear: Production launch announcement of EurexOTC Clear Release 13.0

Eurex Clearing Circular 045/22 Production launch announcement of EurexOTC Clear Release 13.0

1. Introduction

With this circular, Eurex Clearing would like to announce the production launch of EurexOTC Clear Release 13.0 (OTC Release 13.0) on Monday, 27 June 2022. All EurexOTC Clear Members are affected by the introduction of OTC Release 13.0.

Production start: 27 June 2022

Learn now more about EurexOTC Clear Release 13.0 on our dedicated initiative page under the following link: Support > Initiatives & Releases > EurexOTC Clear Releases > EurexOTC Clear Release 13.0. Circulars, timeline and much more information is available there for you.

2.  Required action

The functions and services introduced with this release (such as reports) might have an impact on the report and FpML processing of EurexOTC Clear Members. 

After the batch processing on Friday, 24 June 2022, reports are created based on EurexOTC Clear Release 12.1 formats. Intraday and End-of-Day reports that are created on Monday, 27 June 2022, start of business, will be created based on OTC Release 13.0 formats.

3.  Details of the initiative

A. Documentation for OTC Release 13.0

As announced with Eurex Clearing circular 007/22 and documented in the Functional Release Notes, there are enhancements and changes relevant for OTC IRS Swap Participants.

Further details on enhancements and changes can be found in the functional and technical documentations, which are updated with OTC Release 13.0. Final versions of all documents, samples and XSD files have been published and are available in the Member Section of Deutsche Börse Group under the following path respectively:

Resources > Eurex Clearing > Documentation & Files > EurexOTC Clear > System documentation

B. Changes to be introduced with EurexOTC Clear Release 13.0

  • The Czech Koruna (CZK) and Hungarian Forint (HUF) Product Extensions 
  • Re-mapping of IRS trades’ stubs referencing to USD LIBOR 1W or 2M
  • Trade Booking via the Trade Entry API interface
  • MC-API: change on the ETD template
  • Creation of new trade after PTE trade transfer to CM
  • GUI enhancements
  • Report changes

Eurex Clearing notes that the actual go-live of the service to clear products in the currencies CZK and HUF is to be determined upon regulatory approval. With OTC Release 13.0, technical readiness of the service is achieved, and members have the possibility to test the clearing of products in the new currencies in the simulation environment. Clearing Members will be informed at the later stage via a dedicated communication.

Detailed information about each release item has been published on the respective Initiatives page under the following link: Support > Initiatives & Releases > EurexOTC Clear Releases > EurexOTC Clear Release 13.0 and documented in the Functional Release Notes.

In connection with the introduction, please consider as well the “EurexOTC Clear Release Known Limitations” list which has already been updated and published in the Member Section of Deutsche Börse Group under the following path:

Resources > Eurex Clearing > Documentation & Files > EurexOTC Clear > General question log & Known limitations

Unless the context requires otherwise, terms used and not otherwise defined in this circular shall have the meaning ascribed to them in the Clearing Conditions or FCM Clearing Conditions of Eurex Clearing AG, as applicable.
 

Further information

Recipients:

All Clearing Members, Basic Clearing Members, FCM Clearing Members, Disclosed Direct Clients of Eurex Clearing AG and vendors 

Target groups:

Front Office/Trading, Middle + Backoffice, IT/System Administration, Auditing/Security Coordination

Related circular:

Eurex Clearing circular 007/22

Related Newsflashes:

Eurex Clearing Readiness Newsflash as of 28 April 2022
Eurex Clearing Readiness Newsflash as of 23 May 2022

Contact:

client.services@eurex.com 

Web:

Support > Initiatives & Releases > EurexOTC Clear Releases > EurexOTC Clear Release 13.0

Authorized by:

Dmitrij Senko